Wei Gong

机构：XinHua Hospital, Soochow University, Southern Medical University Shenzhen Hospital, Shenzhen Institutes of Advanced Technology, First Affiliated Hospital of Soochow University · ORCID：0000-0002-9949-6207

发表论文 136 篇 · 总被引 5129 次 · h-index 38

代表论文

• Efficacy and safety of tislelizumab plus lenvatinib as first-line treatment in patients with unresectable hepatocellular carcinoma: a multicenter, single-arm, phase 2 trial (2024 · BMC Medicine · 被引 33)
• Efficacy and safety of human umbilical cord-derived mesenchymal stem cells in the treatment of refractory immune thrombocytopenia: a prospective, single arm, phase I trial (2024 · Signal Transduction and Targeted Therapy · 被引 33)
• PTBP3 Mediates IL‐18 Exon Skipping to Promote Immune Escape in Gallbladder Cancer (2024 · Advanced Science · 被引 25)
• Single-cell characterization of infiltrating T cells identifies novel targets for gallbladder cancer immunotherapy (2024 · Cancer Letters · 被引 20)
• Multimodal integration of liquid biopsy and radiology for the noninvasive diagnosis of gallbladder cancer and benign disorders (2025 · Cancer Cell · 被引 19)
• Applications of machine learning-assisted extracellular vesicles analysis technology in tumor diagnosis (2025 · Computational and Structural Biotechnology Journal · 被引 14)